UNSPSC 85812813: Introduction of monoclonal antibody into upper gi, percutaneous approach
Commodity
Code facts
- Part of
-
-
85000000
-
85810000
- 85812800
-
85810000
-
85000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 85812813
Definition
This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of monoclonal antibody into upper gi, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0G30M
About UNSPSC 85812813
UNSPSC 85812813 Introduction of monoclonal antibody into upper GI, percutaneous approach is a Commodity code that shows minimal recent state and local procurement activity aligned with its nominal scope. The five recent opportunities tagged under this code encompass virtual urgent care, general medical services, comprehensive elder care (PACE), rural health network facilitation, cancer registry services, handheld retinal screening devices, EMT staffing, employee health clinic administration, occupational health services, histology lab work, travel nurse staffing, independent medical evaluations, EMS medical direction, psychological testing, wellness platforms, recovery audit services, comprehensive wellness programming, nursing home placement, tobacco cessation counseling, naloxone vending infrastructure, orientation and mobility services, student support services, opioid use disorder treatment and recovery programs, youth crisis stabilization, day treatment programs, health maintenance services, multisystemic therapy, and radiology reads—none of which involve monoclonal antibody infusion or upper gastrointestinal endoscopic procedures. The code appears to reflect a specialized clinical procedure with no current state or local demand signal; the recent opportunities represent a wholesale mismatch between the code's nominal scope and actual procurement activity.
The issuing bodies in the recent dataset span state health departments (Nevada Health Authority, Texas Health and Human Services Commission, Colorado Department of Human Services, New Jersey Department of Health, Illinois Secretary of State), county health systems and departments (Santa Clara, San Mateo, DeKalb County Georgia, Seminole County Florida, Brevard County Florida, Boulder County Colorado, Cobb County Georgia, Forsyth County Georgia, Ventura County California, Jackson County Missouri, Rockland County New York, Sedgwick County Kansas, Fairfax County Virginia, Solano County California), municipal departments and authorities (Inland Empire Health Plan California, City of Phoenix, City of Atlanta, City of Ocala Florida, Events DC), school districts (Parkway School District), and independent transit or cooperative authorities (H-GAC, Sourcewell, Region 7 Purchasing Cooperative). Geographic activity spans California, Texas, Nevada, Colorado, Georgia, Florida, Kansas, New York, Virginia, Illinois, Washington, Oregon, Missouri, and North Carolina, with no concentration pattern. The code shows no recent state or local procurement activity for monoclonal antibody introduction or related gastrointestinal interventions; vendors should not pursue opportunities under this code in the near term.
Quick answers
What is UNSPSC 85812813?
UNSPSC 85812813 is Introduction of monoclonal antibody into upper gi, percutaneous approach, a commodity in UNSPSC 85000000, Healthcare Services.
Which NIGP codes match UNSPSC 85812813?
UNSPSC 85812813 maps to 1 NIGP code, 94848 Health Care Services (Not Otherwise Classified).
On GovTribe
See everything under UNSPSC 85812813
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code